RASSF3: A Potential Drug Target for Cell Signaling and Cell Cycle Regulation

Target Name: RASSF3

NCBI ID: G283349

RASSF3

RASSF3: A Potential Drug Target for Cell Signaling and Cell Cycle Regulation

The Ras association (RalGDS/AF-6) domain family member 3 (RASSF3) is a protein that plays a crucial role in cell signaling pathways. It is a member of the Rass family, which is known for its role in cell signaling and development . RASSF3 is a 21-kDa protein that is expressed in a wide range of tissues and cells. It is highly conserved, with a calculated pI of 4.75 and a predicted localization in the cytoplasm.

The RASSF3 protein is involved in several signaling pathways, including the G1/S signaling pathway, the G0/G1 signaling pathway, and the G2/M signaling pathway. In these pathways, RASSF3 functions as a positive regulator of cell growth, cell division, and cell survival. It plays a key role in the regulation of cell cycle progression, and is involved in the determination of cell cycle progression states.

RASSF3 is also involved in the regulation of cell adhesion and migration. It is a negative regulator of the migration of cancer cells, and has been shown to play a role in the development of cancer. RASSF3 has also been shown to be involved in the regulation of cell survival, by preventing apoptosis and promoting cell survival.

RASSF3 is a potential drug target, due to its involvement in several important signaling pathways. It is a good candidate for small molecule inhibitors, such as inhibitors of the Rass family. These inhibitors have the potential to disrupt cell signaling pathways and disrupt cell growth and division.

In conclusion, the RASSF3 protein is a key regulator of cell signaling pathways, and is involved in the regulation of cell cycle progression, adhesion, and survival. It is a potential drug target, due to its involvement in several important signaling pathways. Further research is needed to fully understand the role of RASSF3 in cell signaling and development.

Protein Name: Ras Association Domain Family Member 3

The "RASSF3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RASSF3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets